| MEDPACE HOLDINGS DL-,01 |
| USA |
| Gesundheit |
| US58506Q1094 / A2APTV |
| 01P (Frankfurt) / MEDP (NASDAQ) |
| FRA:01P, ETR:01P, 01P:GR, NASDAQ:MEDP |
| - |
| https://www.medpace.com/ |
|
Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehen..
>Volltext.. |
| 10952.52 Mio. EUR |
| 10514.35 Mio. EUR |
| 2297.21 Mio. EUR |
| 506.93 Mio. EUR |
| 394.89 Mio. EUR |
| 13.93 EUR |
| 125.31 Mio. EUR |
| 559.82 Mio. EUR |
| - |
| 0.49 |
| 16.29% |
| 3.53% |
| - |
| - |
| - |
| - |
| MEDPACE |
| 01.06.26 |
|
||||
|
||||
|